Invitrogen™ Human CD30 Ligand/TNFSF8 ELISA Kit

Ref.: BL-RE-090646Manufacturer ref.: EH84RB 96 tests
€732.00 excl. VAT

Human CD30 Ligand/TNFSF8 quantitates human CD30 Ligand/TNFSF8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD30 Ligand/TNFSF8.

Accession number
CD153 ; antigène CD153 ; ligand antigène CD30 ; ligand CD30 ; Cd30l ; CD30-L ; CD30LG ; CD30ligand ; Tnfsf8 ; TNLG3A ; membre de la superfamille (ligand) du facteur de nécrose tumorale 8 ; superfamille (ligand) du facteur de nécrose tumorale 8 ; ligand du facteur de nécrose tumorale 3 A ; membre de la superfamille de ligand du facteur de nécrose tumorale 8 ; membre de la superfamille du facteur de nécrose tumorale 8
Dose range
0.123 to 30 ng/ml
Sensitivity of the dosage
0.12 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human CD30 Ligand/TNFSF8 quantitates human CD30 Ligand/TNFSF8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD30 Ligand/TNFSF8.

Human CD30 Ligand/TNFSF8 quantitates human CD30 Ligand/TNFSF8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD30 Ligand/TNFSF8.

The ligand for CD30 is CD30L (CD153). The CD30-CD30L bond allows for the mediating of pleiotropic effects, including cell proliferation, activation, differentiation and apoptotic cell death. CD30 plays an essential role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulation molecule in the negative thymic selection. In addition to its expression in Hodgkin and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin lymphomas (including Burkitt lymphomas), virus-infected T and B cells, and normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2 cytokines and on thymocytes of CD4+/CD8+ that coexpress CD45RO and IL4 receptors.

Sensitivity

Sensitivity of the dosage: 0.12 ng/ml.

Measurement range

Dose range: 0.123 to 30 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CD153.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17184833
Specifications
Accession numberCD153; CD153 antigen; CD30 antigen ligand; CD30 ligand; Cd30l; CD30-L; CD30LG; CD30ligand; Tnfsf8; TNLG3A; member of the superfamily (ligand) of tumour necrosis factor 8; superfamily (ligand) of tumour necrosis factor 8; ligand of tumour necrosis factor 3A; member of the
Dose range0.123 to 30 ng/ml
Sensitivity of the dosage0.12 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P32971
Gene symbol(s)Tnfsf8
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetCD153
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH84RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.